LÄS MER

TURBOKRAFT FÖR DINA SPERMIER!

Högeffektiv behandling

Före

Efter

Ett spermiogram visar koncentration, rörlighet och form för spermierna. Videon till höger visar med tydlighet skillnaden efter en tre månaders behandling med PROFERTIL® Male.

UNIKA EGENSKAPER

PROFERTIL® ist das erste diätetische Lebensmittel zur Optimierung 
der Spermienqualität.

I korthet:

Male infertility has many causes – in industrialized countries, genetics, stress, changes in life patterns and dietary habits all lead to dramatic reductions in sperm cell production and quality. PROFERTIL® is a clinically-tested and patented formula, developed specifically to optimize sperm quality and to treat male sterility. Clinical studies show that taking PROFERTIL® for at least 3 months significantly improves sperm quality. No other formula has beaten its pregnancy rate of Ø 26-41%.

INTAKT DNA STRUKTUR

En vital faktor för ett friskt barn

Avbrott i spermiens DNA kedja ökar markant risken för missfall

In the process of cell division, DNA is copied and transferred to each new cell. If the DNA strands in sperm are damaged, the process of cell division may be disrupted, stopping embryonic development entirely. PROFERTIL® reliably protects sperm DNA from damage.

Sources:
Sedo C.A. et al.; JBRA Assist Reprod. 2017;21(4):343-350.
Cohen-Bacrie P. et al; Fertility & Sterility 2009, 19(5): 1801-1805.
Robinson et al. Hum Rep 2012:10, 2908-2917.
Hachem et al. Int J Womens Health: 2017:9, 331-345.
Lipovac M. et al.; EMJ Urol. 2014;1:60-65.
Eidenberger F. et al.; Fertility & Reproduction 2019; 1:136-140. First results presented by Prof. Dr. Martin Imhof at Aspire 2019.

ENDAST TVÅ KAPSLAR OM DAGEN

PROfertl®: a patented formula.

Directions for use

PROFERTIL® is available as a 1-month pack (60 pills) and a 3-month pack (180 pills). Take two capsules per day with or after a meal and together with something to drink. The capsules should be taken for a period of at least three months in order to optimize each individual phase of the spermatogenesis. However, PROfertil® can and should be continued until pregnancy. For specific questions regarding the optimal duration of intake and for additional questions, please consult your physician.

To be used under medical supervision. Please consult your physician before first use or when changing the recommended directions for use.

HUR ER DRÖM OM ETT EGET BARN KAN BLI VERKLIGHET

ATT FÖRBEREDA SIG INFÖR GRAVIDITETEN

BEHANDLINGEN SOM ÄR UNIK OCH SOM REDAN ANVÄNDS I MER ÄN 70 LÄNDER VÄRLDEN ÖVER

Sammanfattningsvis:

  • Significantly improves all parameters in sperm necessary for successful conception and pregnancy: motility, morphology, count and volume of sperm 1-4)
  • Significant reduction of DNA fragmentation in sperm cells 5-6)
  • Pregnancy rate: avg. 26-41%
  • Present in over 70 countries
  • Made in Austria / GMP quality
  1. Schauer I et al.; Micronutrients as an alternative to fertility treatment in men with subclinical varicocele.; European Association of Urology, Annual meeting, Abstract, Bratislava, Oct 2010.
  2. Imhof M et al.; Improvement of sperm quality after micronutrient supplementation.; ESPEN 2012; 7: e50-e53.
  3. Imhof M et al.; The use of the nutraceutical “PROFERTIL®” – a dietary management of the “male factor”, for the improvement of semen quality.; European Association of Urology, Annual meeting, Abstract, Bratislava, Oct 2010.
  4. Lipovac et al.; Comparison of the effect of a combination of eight micronutrients versus a standard mono preparation on sperm parameters.; Reproductive Biology and Endocrinology (2016) 14:84.
  5. Lipovac M et al.; Increased Hyaluronan Acid Binding Ability of spermatozoa indicating a better maturity, morphology, and higher DNA integrity after micronutrient supplementation.; European Medical Journal 2014; 1:60-65.
  6. Eidenberger F et al.; Measured with Sperm Chromatin Dispersion (SCD) Technique: Will DNA Integrity in Spermatozoa Increase After Micronutrient Supplementation?; Fertility & Reproduction 2019; 1:136-140.; First results presented by Prof. Dr. Martin Imhof at Aspire 2019.